Arimoto-Kobayashi Sakae, Hida Ryoko, Fujii Nana, Mochioka Ryosuke
Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 700-8530, Okayama, Japan.
Faculty of Pharmaceutical Sciences, Okayama University, 700-8530, Okayama, Japan.
Genes Environ. 2021 Nov 12;43(1):50. doi: 10.1186/s41021-021-00225-y.
Mutation, inflammation, and oxidative damage including lipid-peroxidation are factors involved in the development of cancer. We investigated the antimutagenic, in vivo and in vitro anti-inflammatory, and antioxidative effects of the juice of Vitis ficifolia var. ganebu (known as Ryukyu-ganebu in Japan) harvested in Kuchinoshima island (hereafter, the juice is referred to as ganebu-K) in comparison with the juice of Vitis coignetiae (crimson glory vine, known as yamabudo in Japan; hereafter, the juice is referred to as yamabudo) which we found antimutagenic and anti-inflammatory effects.
Ganebu-K inhibited the mutagenic activity of several carcinogens, MeIQx, IQ, Trp-P-2(NHOH), and MNNG, model compounds of tumor initiation. Using S. typhimurium YG7108, a strain lacking O-methylguanine DNA methyltransferases, ganebu-K showed no significant inhibition of the mutagenicity of MNNG. Thus, DNA repair of O-methylguanine produced by MNNG might be an antimutagenic target of the components in ganebu-K. Topical application of ganebu-K to the dorsal sides of mice resulted in potent suppression of acute edema induced by 12-O-tetradecanoylphorbol-13-acetate (TPA). Ganebu-K, but not yamabudo, exhibited significant inhibition of the induction of prostaglandin E (PGE2) induced by TPA. Components contained in ganebu-K, but not in yamabudo, might be responsible for the inhibition of the induction of PGE2. Ganebu-K inhibited in vivo lipid peroxidation and decreased the level of glutamic oxaloacetic transaminase induced by CCL treatment.
These results suggest that the active components in ganebu-K juice are not the same as those in yamabudo, and the components in ganebu-K are attractive candidates as chemopreventive agents.
突变、炎症以及包括脂质过氧化在内的氧化损伤是参与癌症发生发展的因素。我们研究了小叶葡萄(在日本称为琉球甘葡萄)果实汁液(以下简称甘葡萄-K)的抗诱变、体内外抗炎及抗氧化作用,并与已发现具有抗诱变和抗炎作用的五叶地锦(在日本称为山葡萄;以下简称山葡萄)果实汁液进行了比较。
甘葡萄-K抑制了几种致癌物(MeIQx、IQ、Trp-P-2(NHOH)和MNNG)的诱变活性,这些致癌物是肿瘤起始的模型化合物。使用缺乏O-甲基鸟嘌呤DNA甲基转移酶的鼠伤寒沙门氏菌YG7108,甘葡萄-K对MNNG的诱变性没有显著抑制作用。因此,MNNG产生的O-甲基鸟嘌呤的DNA修复可能是甘葡萄-K中成分的抗诱变靶点。将甘葡萄-K局部涂抹于小鼠背部,可有效抑制由12-O-十四酰佛波醇-13-乙酸酯(TPA)诱导的急性水肿。甘葡萄-K而非山葡萄对TPA诱导的前列腺素E(PGE2)的产生有显著抑制作用。甘葡萄-K中含有的成分而非山葡萄中的成分可能是抑制PGE2产生的原因。甘葡萄-K抑制体内脂质过氧化,并降低CCL处理诱导的谷氨酸草酰乙酸转氨酶水平。
这些结果表明,甘葡萄-K汁液中的活性成分与山葡萄中的不同,甘葡萄-K中的成分是有吸引力的化学预防剂候选物。